CC BY-NC-ND 4.0 · Laryngorhinootologie 2019; 98(S 02): S71
DOI: 10.1055/s-0039-1685996
Tipifarnib as a potent therapeutic agent in HRAS-mutated head and neck cancers
S Hackenberg
1
Univ. HNO-Klinik, Würzburg
,
C Sayehli
2
ECTU Uniklinikum Würzburg, Würzburg
,
U Müller-Richter
3
Univ. MKG Klinik, Würzburg
,
A Scherzad
4
Univ. HNO Klinik, Würzburg
› Author Affiliations
